Guohui Li Selected Research

Colorectal Neoplasms (Colorectal Cancer)

12/2021	Correction to: Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex.
5/2020	Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guohui Li Research Topics

Disease

34	Neoplasms (Cancer) 07/2022 - 10/2003
9	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2019
9	Infections 09/2019 - 08/2008
5	Inflammation (Inflammations) 06/2021 - 08/2010
5	Parkinson Disease (Parkinson's Disease) 10/2020 - 08/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2020
4	Neoplasm Metastasis (Metastasis) 03/2021 - 01/2019
4	Breast Neoplasms (Breast Cancer) 02/2021 - 01/2016
3	COVID-19 04/2022 - 11/2021
3	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 10/2012
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 03/2018
3	Carcinogenesis 01/2020 - 01/2016
3	Virus Diseases (Viral Diseases) 06/2019 - 01/2017
2	Hypersensitivity (Allergy) 01/2022 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 05/2020
2	Ischemic Stroke 02/2021 - 11/2016
2	Glioma (Gliomas) 01/2021 - 03/2016
2	Brain Neoplasms (Brain Tumor) 01/2021 - 10/2019
2	Lewis Lung Carcinoma 01/2021 - 03/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 07/2015
2	Carcinoma (Carcinomatosis) 10/2020 - 10/2003
2	Hypoxia (Hypoxemia) 01/2020 - 03/2016
2	Body Weight (Weight, Body) 01/2020 - 07/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 03/2016
2	Cognitive Dysfunction 05/2015 - 02/2014
2	Pheochromocytoma 02/2015 - 07/2012
2	Leukemia 03/2012 - 09/2011
2	Hypothalamic hamartomas 04/2011 - 10/2008
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Anemia 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Hepatoblastoma 10/2021
1	Wilms Tumor (Wilm's Tumor) 10/2021
1	Disease Progression 03/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 10/2021 - 05/2008
13	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
7	Biological ProductsIBA 10/2020 - 01/2011
5	Phosphotransferases (Kinase)IBA 01/2022 - 01/2013
5	Peptides (Polypeptides)IBA 12/2021 - 01/2012
4	Messenger RNA (mRNA)IBA 10/2021 - 05/2008
4	Neuroprotective AgentsIBA 11/2016 - 08/2012
3	xihuangIBA 07/2022 - 10/2020
3	EnzymesIBA 01/2022 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 02/2021 - 12/2017
3	si-jun-zi-tangIBA 01/2021 - 01/2019
3	AntioxidantsIBA 01/2021 - 09/2011
3	Liposomes (Liposome)IBA 06/2020 - 12/2015
3	GABA-A Receptors (GABA(A) Receptor)IBA 04/2011 - 07/2007
2	anlotinibIBA 07/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 11/2006
2	Immune Checkpoint InhibitorsIBA 06/2022 - 03/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2020
2	Docetaxel (Taxotere)FDA Link 01/2022 - 09/2021
2	SurvivinIBA 12/2021 - 05/2020
2	Antiviral Agents (Antivirals)IBA 11/2021 - 01/2018
2	6-methyladenineIBA 10/2021 - 10/2020
2	pembrolizumabIBA 09/2021 - 03/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 01/2021
2	lorlatinibIBA 01/2021 - 01/2020
2	oxyphylla AIBA 10/2020 - 01/2016
2	Amino Acids FDA Link 06/2020 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 01/2011
2	MicroRNAs (MicroRNA)IBA 06/2019 - 12/2012
2	Immunoglobulin G (IgG)IBA 05/2008 - 10/2003
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2022
1	Particulate MatterIBA 04/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	HydrolasesIBA 01/2022
1	Moclobemide (Arima)IBA 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	SphingolipidsIBA 01/2022
1	CystathionineIBA 01/2022
1	SolventsIBA 01/2022
1	Taxoids (Taxanes)IBA 01/2022
1	Leucovorin (Folinic Acid)FDA Link 01/2022
1	HomocysteineIBA 01/2022
1	LipidsIBA 01/2022
1	Albumin-Bound Paclitaxel FDA Link 01/2022
1	Cysteine Proteases (Cysteine Protease)IBA 11/2021
1	Peptide Hydrolases (Proteases)FDA Link 11/2021
1	N-methyladenosineIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Sincalide FDA Link 05/2021
1	atezolizumabIBA 03/2021
1	B7-H1 AntigenIBA 03/2021
1	PlatinumIBA 03/2021

Therapy/Procedure

18	Therapeutics 07/2022 - 10/2003
2	Castration 05/2018 - 03/2018
2	Lasers (Laser) 05/2008 - 10/2003
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2022
1	Immunotherapy 06/2022
1	Drug Therapy (Chemotherapy) 03/2021
1	Radiotherapy 01/2021